 | • レポートコード：MRC2103G052 • 出版社/出版日：Transparency Market Research / 2020年10月30日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide Licence | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、世界の動物分子診断市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、製品タイプ別（機器・ソフトウェア、キット・試薬、サービス）分析、技術別分析、疾病タイプ別分析、動物タイプ別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成でまとめております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場動向 ・動物分子診断の世界市場規模：製品タイプ別（機器・ソフトウェア、キット・試薬、サービス） ・動物分子診断の世界市場規模：技術別 ・動物分子診断の世界市場規模：疾病タイプ別 ・動物分子診断の世界市場規模：動物タイプ別 ・動物分子診断の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Veterinary Molecular Diagnostics Market – Scope of the Report
TMR’s report on the global veterinary molecular diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global veterinary molecular diagnostics market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global veterinary molecular diagnostics market from 2020 to 2030.
The report is prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the veterinary molecular diagnostics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global veterinary molecular diagnostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global veterinary molecular diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary molecular diagnostics market.
The report delves into the competition landscape of the global veterinary molecular diagnostics market. Key players operating in the global veterinary molecular diagnostics market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global veterinary molecular diagnostics market profiled in this report.
Key Questions Answered in Veterinary Molecular Diagnostics Market Report
What is the sales/revenue generated by veterinary molecular diagnostics across all regions during the forecast period?
What are the opportunities in the global veterinary molecular diagnostics market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which product type segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Veterinary Molecular Diagnostics Market – Research Objectives and Research Approach
The comprehensive report on the global veterinary molecular diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global veterinary molecular diagnostics market in terms of product type, technology, disease type, animal type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global veterinary molecular diagnostics market.
レポート目次1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Veterinary Molecular Diagnostics Market Forecast
4.5. Global Veterinary Molecular Diagnostics Market Outlook
5. Market Outlook
5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)
5.2. Pet Ownership Statistics
5.3. List of Pathogens for responsible for Canine, Feline, and Equine Diseases
5.4. Covid-19 Impact Analysis
5.5. Pros and Cons of Each Type of PCR Test
5.6. Technological Advancement
5.7. Most commonly Used Instruments for Veterinary Diagnostics
5.8. Veterinary Medical Device Regulation
6. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type
6.1. Introduction
6.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
6.3. Global Veterinary Molecular Diagnostics Market Forecast, by Product Type
6.3.1. Instruments & Software
6.3.2. Kits & Reagents
6.3.3. Services
6.4. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type
7. Global Veterinary Molecular Diagnostics Market Analysis, by Technology
7.1. Introduction
7.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
7.3. Global Veterinary Molecular Diagnostics Market Forecast, by Technology
7.3.1. Conventional PCR
7.3.2. Singleplex PCR
7.3.3. Multiplex PCR
7.3.4. Real-time PCR
7.3.5. Others
7.4. Global Veterinary Molecular Diagnostics Market Analysis, by Technology
8. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type
8.1. Introduction
8.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
8.3. Global Veterinary Molecular Diagnostics Market Forecast, by Disease Type
8.3.1. Vector-borne Diseases
8.3.2. Respiratory Pathogens
8.3.3. Diarrhea Pathogens
8.3.4. Others
8.4. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type
9. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type
9.1. Introduction
9.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
9.3. Global Veterinary Molecular Diagnostics Market Forecast, by Animal Type
9.3.1. Companion Animals
9.3.1.1. Canine
9.3.1.2. Feline
9.3.1.3. Others
9.3.2. Livestock Animals
9.4. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type
10. Global Veterinary Molecular Diagnostics Market Analysis, by End-user
10.1. Introduction
10.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
10.3. Global Veterinary Molecular Diagnostics Market Forecast, by End-user
10.3.1. Hospitals/Clinics
10.3.2. Reference Laboratories
10.4. Global Veterinary Molecular Diagnostics Market Analysis, by End-user
11. Global Veterinary Molecular Diagnostics Market Analysis, by Region
11.1. Global Veterinary Molecular Diagnostics Market Scenario, by Region/Country
11.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Region
11.3. Global Veterinary Molecular Diagnostics Market Forecast, by Region
11.3.1. North America
11.3.2. Europe
11.3.3. Asia Pacific
11.3.4. Latin America
11.3.5. Middle East & Africa
12. North America Veterinary Molecular Diagnostics Market Analysis
12.1. North America Veterinary Molecular Diagnostics Market Overview
12.2. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country
12.3. North America Veterinary Molecular Diagnostics Market Forecast, by Country
12.3.1. U.S.
12.3.2. Canada
12.4. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
12.5. North America Veterinary Molecular Diagnostics Market Forecast, by Product Type
12.5.1. Instruments & Software
12.5.2. Kits & Reagents
12.5.3. Services
12.6. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
12.7. North America Veterinary Molecular Diagnostics Market Forecast, by Technology
12.7.1. Conventional PCR
12.7.2. Singleplex PCR
12.7.3. Multiplex PCR
12.7.4. Real-time PCR
12.7.5. Others
12.8. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
12.9. North America Veterinary Molecular Diagnostics Market Forecast, by Disease Type
12.9.1. Vector-borne Diseases
12.9.2. Respiratory Pathogens
12.9.3. Diarrhea Pathogens
12.9.4. Others
12.10. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
12.11. North America Veterinary Molecular Diagnostics Market Forecast, by Animal Type
12.11.1. Companion Animals
12.11.1.1. Canine
12.11.1.2. Feline
12.11.1.3. Others
12.11.2. Livestock Animals
12.12. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
12.13. North America Veterinary Molecular Diagnostics Market Forecast, by End-user
12.13.1. Hospitals/Clinics
12.13.2. Reference Laboratories
13. Europe Veterinary Molecular Diagnostics Market Analysis
13.1. Europe Veterinary Molecular Diagnostics Market Overview
13.2. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Europe Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
13.3.1. Germany
13.3.2. U.K.
13.3.3. France
13.3.4. Italy
13.3.5. Spain
13.3.6. Rest of Europe
13.4. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
13.5. Europe Veterinary Molecular Diagnostics Market Forecast, by Product Type
13.5.1. Instruments & Software
13.5.2. Kits & Reagents
13.5.3. Services
13.6. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
13.7. Europe Veterinary Molecular Diagnostics Market Forecast, by Technology
13.7.1. Conventional PCR
13.7.2. Singleplex PCR
13.7.3. Multiplex PCR
13.7.4. Real-time PCR
13.7.5. Others
13.8. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
13.9. Europe Veterinary Molecular Diagnostics Market Forecast, by Disease Type
13.9.1. Vector-borne Diseases
13.9.2. Respiratory Pathogens
13.9.3. Diarrhea Pathogens
13.9.4. Others
13.10. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
13.11. Europe Veterinary Molecular Diagnostics Market Forecast, by Animal Type
13.11.1. Companion Animals
13.11.1.1. Canine
13.11.1.2. Feline
13.11.1.3. Others
13.11.2. Livestock Animals
13.12. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
13.13. Europe Veterinary Molecular Diagnostics Market Forecast, by End-user
13.13.1. Hospitals/Clinics
13.13.2. Reference Laboratories
14. Asia Pacific Veterinary Molecular Diagnostics Market Analysis
14.1. Asia Pacific Veterinary Molecular Diagnostics Market Overview
14.2. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
14.3.1. China
14.3.2. Japan
14.3.3. India
14.3.4. Australia & New Zealand
14.3.5. Rest of Asia Pacific
14.4. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
14.5. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Product Type
14.5.1. Instruments & Software
14.5.2. Kits & Reagents
14.5.3. Services
14.6. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
14.7. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Technology
14.7.1. Conventional PCR
14.7.2. Singleplex PCR
14.7.3. Multiplex PCR
14.7.4. Real-time PCR
14.7.5. Others
14.8. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
14.9. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Disease Type
14.9.1. Vector-borne Diseases
14.9.2. Respiratory Pathogens
14.9.3. Diarrhea Pathogens
14.9.4. Others
14.10. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
14.11. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Animal Type
14.11.1. Companion Animals
14.11.1.1. Canine
14.11.1.2. Feline
14.11.1.3. Others
14.11.2. Livestock Animals
14.12. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
14.13. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by End-user
14.13.1. Hospitals/Clinics
14.13.2. Reference Laboratories
15. Latin America Veterinary Molecular Diagnostics Market Analysis
15.1. Latin America Veterinary Molecular Diagnostics Market Overview
15.2. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
15.3. Latin America Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
15.3.1. Brazil
15.3.2. Mexico
15.3.3. Rest of Latin America
15.4. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
15.5. Latin America Veterinary Molecular Diagnostics Market Forecast, by Product Type
15.5.1. Instruments & Software
15.5.2. Kits & Reagents
15.5.3. Services
15.6. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
15.7. Latin America Veterinary Molecular Diagnostics Market Forecast, by Technology
15.7.1. Conventional PCR
15.7.2. Singleplex PCR
15.7.3. Multiplex PCR
15.7.4. Real-time PCR
15.7.5. Others
15.8. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
15.9. Latin America Veterinary Molecular Diagnostics Market Forecast, by Disease Type
15.9.1. Vector-borne Diseases
15.9.2. Respiratory Pathogens
15.9.3. Diarrhea Pathogens
15.9.4. Others
15.10. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
15.11. Latin America Veterinary Molecular Diagnostics Market Forecast, by Animal Type
15.11.1. Companion Animals
15.11.1.1. Canine
15.11.1.2. Feline
15.11.1.3. Others
15.11.2. Livestock Animals
15.12. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
15.13. Latin America Veterinary Molecular Diagnostics Market Forecast, by End-user
15.13.1. Hospitals/Clinics
15.13.2. Reference Laboratories
16. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis
16.1. Middle East & Africa Veterinary Molecular Diagnostics Market Overview
16.2. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
16.3. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
16.3.1. GCC Countries
16.3.2. South Africa
16.3.3. Rest of Middle East & Africa
16.4. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
16.5. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Product Type
16.5.1. Instruments & Software
16.5.2. Kits & Reagents
16.5.3. Services
16.6. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
16.7. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Technology
16.7.1. Conventional PCR
16.7.2. Singleplex PCR
16.7.3. Multiplex PCR
16.7.4. Real-time PCR
16.7.5. Others
16.8. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
16.9. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Disease Type
16.9.1. Vector-borne Diseases
16.9.2. Respiratory Pathogens
16.9.3. Diarrhea Pathogens
16.9.4. Others
16.10. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
16.11. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Animal Type
16.11.1. Companion Animals
16.11.1.1. Canine
16.11.1.2. Feline
16.11.1.3. Others
16.11.2. Livestock Animals
16.12. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
16.13. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by End-user
16.13.1. Hospitals/Clinics
16.13.2. Reference Laboratories
17. Competition Landscape
17.1. Competition Matrix
17.2. Global Veterinary Molecular Diagnostics Market Share Analysis, by Company
17.3. Company Profiles
17.3.1. IDEXX Laboratories, Inc.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Thermo Fisher Scientific, Inc.
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Zoetis, Inc.
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Neogen Corporation
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. SWOT Analysis
17.3.4.4. Strategic Overview
17.3.5. bioMérieux SA
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. QIAGEN N.V.
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Biomedica Medizinprodukte GmbH & Co KG
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. SWOT Analysis
17.3.7.4. Strategic Overview
17.3.8. Bioneer
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. SWOT Analysis
17.3.8.4. Strategic Overview
17.3.9. VCA, Inc. (subsidiary of Mars, Incorporated)
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. SWOT Analysis
17.3.9.4. Strategic Overview
17.3.10. ID.VET
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. SWOT Analysis
17.3.10.4. Strategic Overview
Table 01: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 02: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 03: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 04: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 05: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 06: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 07: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 08: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 09: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 10: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 11: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 12: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 13: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 14: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 15: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 16: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 17: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 18: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 19: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 20: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 21: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 22: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 23: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 24: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 25: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 26: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 27: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 28: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 29: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 30: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 31: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 32: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 33: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 34: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 35: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 36: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 37: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 38: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 39: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 40: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 41: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 42: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030